University of Lausanne
- Country
- 🇨🇭Switzerland
- Ownership
- Private
- Established
- 1911-01-01
- Employees
- 101
- Market Cap
- -
- Website
- http://www.unil.ch
Clinical Trials
53
Trial Phases
2 Phases
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (40 trials with phase data)• Click on a phase to view related trials
Complex-Posttraumatic Stress Disorder in Urban Egypt: Pilot Testing of a Culturally-adapted Evidence-Based Treatment Manual and Development of a Culture-specific Diagnostic
- Conditions
- Complex Post-Traumatic Stress Disorder
- First Posted Date
- 2024-06-18
- Last Posted Date
- 2024-06-20
- Lead Sponsor
- University of Lausanne
- Target Recruit Count
- 20
- Registration Number
- NCT06464432
- Locations
- 🇪🇬
The American University in Cairo, Cairo, Egypt
Effectiveness of a Patient-oriented Discharge Summary
- Conditions
- Multimorbidity
- First Posted Date
- 2023-11-08
- Last Posted Date
- 2024-06-20
- Lead Sponsor
- University of Lausanne
- Target Recruit Count
- 84
- Registration Number
- NCT06123546
- Locations
- 🇨🇭
Hôpital de Morges, Morges, Vaud, Switzerland
The Effects of Inspiratory Muscle Training on Endurance Performance in Trained Athletes Under Normoxic and Hypoxic Conditions: A Gender-based Comprehensive Study
- Conditions
- Hypoxia, Altitude
- First Posted Date
- 2023-11-07
- Last Posted Date
- 2023-11-07
- Lead Sponsor
- University of Lausanne
- Target Recruit Count
- 48
- Registration Number
- NCT06121128
The Application of Wide Pulse High Frequency Neuromuscular Electrical Stimulation in Disorders Associated With Motoneuron Hyperexcitability
- Conditions
- Healthy VolunteersStrokeCrampRestless Legs Syndrome
- First Posted Date
- 2023-06-18
- Last Posted Date
- 2023-11-28
- Lead Sponsor
- University of Lausanne
- Target Recruit Count
- 110
- Registration Number
- NCT05908214
- Locations
- 🇨🇭
Bâtiment Synathlon, quartier UNIL-Centre, Lausanne, Switzerland
Orphan Drugs for Inherited Metabolic Diseases
- Conditions
- Inborn Errors of Metabolism
- First Posted Date
- 2023-04-19
- Last Posted Date
- 2024-12-04
- Lead Sponsor
- University of Lausanne
- Target Recruit Count
- 39
- Registration Number
- NCT05818566
- Locations
- 🇨🇭
Lausanne University Hospital, Lausanne, Vaud, Switzerland
- Prev
- 1
- 2
- 3
- 4
- 5
- 11
- Next
News
Epitopea's CryptoMap Platform Identifies Novel Immunotherapy Targets in Melanoma and NSCLC
Epitopea's CryptoMap platform identified 589 non-redundant tumor antigens in cutaneous melanoma and NSCLC, with only 1% derived from mutated sequences.
Aging Impairs CAR-T Cell Therapy Effectiveness Through Metabolic Decline, Swiss Study Reveals
New research from Swiss institutions demonstrates that age-related immune decline significantly reduces the effectiveness of CAR-T cell cancer therapy by impairing mitochondrial function and metabolism.